Prenetics Global Ltd (PRE)
Official siteCONSUMER DEFENSIVE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $322.18M
Last updated: Nov 17, 2026 at 11:06 AM ET
Prenetics Global Ltd (PRE) Financials: Revenue, Profit and Cash Flow
Prenetics Global reported revenue of $92.39M for the fiscal year ended Dec 31, 2025, up 201.7% from the year before. That year, net income was -$37.71M with a net margin of -40.8%, operating cash flow was -$21.81M and free cash flow was -$22.02M. The quarter ended Jun 30, 2026 had revenue of $46.49M and net income of -$8.98M.
Revenue and Margins
The operating margin was -41.3% in the fiscal year ended Dec 2025, the lowest of the 5 years shown with an operating margin. Over the 12 years to Dec 2025, revenue fell from $5.59B, a compound annual decline of 29.0%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $92.39M | +201.7% | 52.8% | -41.3% | -40.8% |
| Dec 2024 | $30.62M | +40.8% | 50.3% | -157.2% | -151.2% |
| Dec 2023 | $21.74M | +65.2% | 40.6% | -238.7% | -288.5% |
| Dec 2022 | $13.16M | +5.0% | 27.5% | -501.5% | -1446.8% |
| Dec 2021 | $12.53M | -80.8% | 28.7% | -452.1% | -1388.4% |
| Dec 2020 | $65.18M | +605.9% | 40.4% | -1.5% | -3.0% |
| Dec 2019 | $9.23M | N/A | 29.4% | -225.3% | -218.2% |
| Dec 2015 | $5.48B | -15.4% | 12.2% | 11.7% | 1.9% |
| Dec 2014 | $6.48B | +15.9% | 21.0% | 20.6% | 16.3% |
| Dec 2013 | $5.59B | N/A | 15.4% | 14.9% | 11.9% |
Income Statement
In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Jun 2026, the net loss narrowed from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2015 | Dec 2014 | Dec 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $92.39M | $30.62M | $21.74M | $13.16M | $12.53M | $65.18M | $9.23M | $5.48B | $6.48B | $5.59B |
| Cost of revenue | $43.60M | $15.22M | $12.91M | $9.55M | $8.93M | $38.83M | $6.52M | $4.76B | $5.12B | $4.68B |
| Gross profit | $48.79M | $15.40M | $8.83M | $3.62M | $3.60M | $26.34M | $2.72M | $668.70M | $1.36B | $860.40M |
| Research and development | $5.13M | $10.92M | $11.66M | $5.99M | $6.39M | $2.78M | $2.99M | $0 | $0 | $0 |
| Operating income | -$38.13M | -$48.14M | -$51.91M | -$66.02M | -$56.66M | -$995.13K | -$20.80M | $642.11M | $1.33B | $833.23M |
| Net income | -$37.71M | -$46.30M | -$62.72M | -$190.45M | -$174.01M | -$1.94M | -$20.14M | $104.38M | $1.05B | $664.01M |
| EBITDA | -$32.19M | N/A | -$47.90M | N/A | N/A | N/A | -$18.57M | N/A | N/A | N/A |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $46.49M | $35.95M | $36.56M | $23.55M | $17.68M | $10.49M | $10.49M | $7.78M | $5.94M | $6.41M | $5.43M | $4.88M |
| Gross profit | $30.20M | $23.28M | $21.74M | $14.02M | $7.29M | $3.90M | $3.90M | $3.95M | $3.77M | $3.78M | $2.67M | $1.65M |
| Operating income | -$21.92M | -$9.71M | -$12.39M | -$6.16M | -$10.06M | -$16.57M | -$17.86M | -$11.81M | -$10.61M | -$9.16M | -$12.19M | -$12.94M |
| Net income | -$8.98M | -$23.10M | -$28.11M | -$7.41M | -$12.41M | -$16.34M | -$16.34M | -$10.67M | -$10.72M | -$8.57M | -$19.05M | -$13.57M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $1.33M by $30.80M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2015 | Dec 2014 | Dec 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $203.52M | $213.57M | $254.17M | $312.13M | $148.51M | $78.88M | $29.69M | $21.41B | $22.27B | $23.04B |
| Current assets | $83.39M | $86.15M | $93.66M | $241.81M | $106.89M | $43.96M | $15.63M | N/A | N/A | N/A |
| Cash and equivalents | $32.13M | $52.25M | $45.71M | $146.66M | $35.29M | $14.49M | $11.52M | $1.58B | $1.31B | $1.50B |
| Total liabilities | $29.01M | $42.23M | $44.01M | $68.67M | $549.40M | $47.88M | $12.83M | $14.50B | $15.17B | $16.27B |
| Short-term debt | $1.33M | $2.76M | $1.50M | $2.88M | $1.67M | $16.34M | $555.75K | N/A | N/A | N/A |
| Long-term debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $820.99M | $820.99M | $820.99M |
| Shareholder equity | $174.60M | $170.39M | $206.36M | $237.06M | -$400.81M | $31.08M | $16.91M | $6.90B | $7.10B | $6.77B |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $153.66M | $175.30M | $203.52M | $196.51M | $199.11M | $213.57M | $213.57M | $235.77M | $233.31M | $243.59M | $254.17M | $276.41M |
| Total liabilities | $60.73M | $54.28M | $29.01M | $35.30M | $48.21M | $42.23M | $42.23M | $55.67M | $42.30M | $40.82M | $44.01M | $47.63M |
| Cash and equivalents | $59.05M | $56.02M | $32.13M | $13.26M | $17.25M | $52.25M | $52.25M | $31.94M | $41.20M | $54.52M | $16.00M | $71.25M |
| Shareholder equity | $93.01M | $121.11M | $174.60M | $161.29M | $150.98M | $170.39M | $170.39M | $178.68M | $188.24M | $199.44M | $206.36M | $224.44M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2015 | Dec 2014 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$21.81M | -$28.87M | -$13.76M | $14.51M | $13.42M | -$2.88M | -$1.88M | $318.81M | $852.60M |
| Capital expenditures | $208.00K | $1.06M | $911.81K | $6.34M | $11.41M | $3.06M | $373.86K | $0 | $0 |
| Free cash flow | -$22.02M | -$29.94M | -$14.68M | $8.17M | $2.00M | -$5.94M | -$2.26M | $318.81M | $852.60M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $190.34M | $190.96M |
| Investing cash flow | -$35.79M | $38.54M | -$82.95M | -$46.14M | -$22.02M | -$5.97M | -$4.60M | $295.27M | N/A |
| Financing cash flow | $37.54M | -$3.34M | -$4.70M | $143.32M | $29.32M | $11.84M | -$569.14K | N/A | N/A |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$15.45M | -$12.12M | -$21.81M | N/A | -$5.28M | -$3.98M | N/A | N/A | N/A | N/A | N/A | $3.77M |
| Capital expenditures | $15.45M | $208.00K | $208.00K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Free cash flow | -$30.91M | -$12.33M | -$22.02M | N/A | -$5.28M | -$3.98M | N/A | N/A | N/A | N/A | N/A | $3.77M |
Frequently Asked Questions About PRE
What is Prenetics Global's annual revenue?
Prenetics Global reported revenue of $92.39M for the fiscal year ended Dec 31, 2025.
How fast is Prenetics Global's revenue growing?
Revenue was up 201.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 91.5%.
Is Prenetics Global profitable?
No. Prenetics Global reported net income of -$37.71M for the fiscal year ended Dec 31, 2025, with a net margin of -40.8%.
How much free cash flow does PRE generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$21.81M minus capital expenditures of $208.00K produced free cash flow of -$22.02M.
How much debt does Prenetics Global have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $1.33M and cash and equivalents of $32.13M.
PRE pages: Overview, Earnings, Forecast, Financials, Competitors